Jeffrey Nelson
Net worth: 55 331 $ as of 2026-07-30
Net worth: 55 331 $ as of 2026-07-30
Jeffrey Nelson is Chief Operating Officer at Milestone Pharmaceuticals, Inc. since 2020.
Formerly, Mr. Nelson was Vice President-Program Management at Oncotelic Therapeutics, Inc. from 2015 to 2017 and Head-Clinical Operations at Axsome Therapeutics, Inc. from 2014 to 2015.
Mr. Nelson completed an undergraduate degree at Brandeis University in 2003.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-01 | 49,848 ( 0.04% ) | 55 331 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Chief Operating Officer | 2020-05-31 |
| Companies | Position | End |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | 2016-12-31 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions